Echo Therapeutics (ECTE) Reports Q2 Loss of $0.82/Share

August 12, 2016 2:45 PM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Echo Therapeutics (NASDAQ: ECTE) reported Q2 EPS of ($0.82), versus ($0.97) reported last year.

For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment